Details for New Drug Application (NDA): 020179

✉ Email this page to a colleague

NDA 020179 describes DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare, Icu Medical Inc, Hospira, B Braun, Miles, Abbott, Fresenius Kabi Usa, and DHL, and is included in forty-nine NDAs. It is available from seven suppliers. Additional details are available on the DEXTROSE 5% IN PLASTIC CONTAINER profile page.

The generic ingredient in DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; potassium chloride; sodium chloride. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dextrose; potassium chloride; sodium chloride profile page.

Tradename:	DEXTROSE 5% IN PLASTIC CONTAINER
Applicant:	Baxter Hlthcare
Ingredient:	dextrose
Patents:	0

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DEXTROSE 5% IN PLASTIC CONTAINER	dextrose	INJECTABLE;INJECTION	020179	NDA	Baxter Healthcare Corporation	0338-0170	0338-0170-01	30 BAG in 1 CARTON (0338-0170-01) / 50 mL in 1 BAG
DEXTROSE 5% IN PLASTIC CONTAINER	dextrose	INJECTABLE;INJECTION	020179	NDA	Baxter Healthcare Corporation	0338-0172	0338-0172-01	30 BAG in 1 CARTON (0338-0172-01) / 100 mL in 1 BAG

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	5GM/100ML
Approval Date:	Dec 7, 1992	TE:	AP	RLD:	Yes

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	50MG/ML
Approval Date:	Dec 7, 1992	TE:	AP	RLD:	Yes

Complete Access Available with Subscription